Comment
doi: 10.1136/annrheumdis-2018-213672.
Epub 2018 May 14.
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor
Affiliations
- PMID: 29760158
- DOI: 10.1136/annrheumdis-2018-213672
Item in Clipboard
Comment
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor
Ann Rheum Dis.
2019 Jul.
No abstract available
Keywords: T cells; autoimmunity; polymyalgia rheumatica.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass.Ann Rheum Dis. 2019 Jul;78(7):e71. doi: 10.1136/annrheumdis-2018-213682. Epub 2018 Jun 20. Ann Rheum Dis. 2019. PMID: 29925509 No abstract available.
Comment on
-
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16. Ann Rheum Dis. 2018. PMID: 29146737
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
